• Educational resources
  • Events
  • Expert Panel
  • Learning Hub
    Learning Hub
    • Bullous Pemphigoid Learning Hub
    • Chronic Spontaneous Urticaria Learning Hub
    • COPD Learning Hub
    • Rhinology Learning Hub
    • Type 2 Asthma Learning Hub
    • Prurigo Nodularis Learning Hub
    • Atopic Dermatitis Learning Hub
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT
  • Contact us

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 - 4.0 - 10/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ThailandChange country/region

Educational Resources

Categories
Dermatology: 
  • Atopic dermatitis
  • Bullous pemphigoid
  • Chronic pruritus of unknown origin
  • Chronic spontaneous urticaria
  • Prurigo nodularis
Pulmonology: 
  • Asthma
  • Chronic obstructive pulmonary disease
Rhinology: 
  • Chronic rhinosinusitis with nasal polyps
Filters
Topic: 
  • Burden of disease
  • Pathophysiology
  • Guidelines and recommendations
  • Clinical management
  • Co-existing type 2 inflammatory diseases
Format: 
  • Expert Video
  • Podcast
  • Slide presentation
  • Infographic
  • Video animation
  • Interactivity
Length: 
  • Short (<5 minutes)
  • Medium (5-15 minutes)
  • Long (> 15 minutes)
Sort by: Newest
  • Newest
  • Oldest
  • A-Z
  • Z-A
Type 2 Inflammation Is a Driving Factor for Atopic Dermatitis and Related Comorbidities
Dermatology
2 min
expert video

Type 2 Inflammation Is a Driving Factor for Atopic Dermatitis and Related Comorbidities

The Patient's Path: Unraveling the Diagnosis and Burden of Bullous Pemphigoid
Dermatology
6 min
videoanimation

The Patient's Path: Unraveling the Diagnosis and Burden of Bullous Pemphigoid

Neuroimmune Dysfunction Is Critical in the Pathophysiology of Prurigo Nodularis
Dermatology
2 min
expert video

Neuroimmune Dysfunction Is Critical in the Pathophysiology of Prurigo Nodularis

Pathways Driving Chronic Airway Remodeling in Asthma
Pulmonology
4 min
videoanimation

Pathways Driving Chronic Airway Remodeling in Asthma

ADVENT On-Air Podcast: The Multifaceted Patient Burden and Drivers of Disease in Prurigo Nodularis
Dermatology
20 min
Podcast

ADVENT On-Air Podcast: The Multifaceted Patient Burden and Drivers of Disease in Prurigo Nodularis

Exploring the Potential Disease-Modifying Approaches in AD
Dermatology
15 min
interactivity

Exploring the Potential Disease-Modifying Approaches in AD

Type 2 Inflammation and Sinonasal Barrier Dysfunction in CRSwNP
Rhinology
4 min
videoanimation

Type 2 Inflammation and Sinonasal Barrier Dysfunction in CRSwNP

ADVENT On Air Podcast: Unmet Needs and Current Treatment Landscape
Dermatology
20 min
Podcast

ADVENT On Air Podcast: Unmet Needs and Current Treatment Landscape

Shared and Distinct: The Role of Type 2 Inflammation in Skin Diseases
Dermatology
25 min
expert video

Shared and Distinct: The Role of Type 2 Inflammation in Skin Diseases

Time to Act: Reducing the Impact of Uncontrolled Disease Through Early Intervention
Dermatology
25 min
expert video

Time to Act: Reducing the Impact of Uncontrolled Disease Through Early Intervention

Beyond Signs and Symptoms: Broadening Treatment Goals in Dermatology
Dermatology
25 min
expert video

Beyond Signs and Symptoms: Broadening Treatment Goals in Dermatology

Low Disease Activity and Disease Stability: Setting New Goals for COPD Care
Pulmonology
2 min
Infographic

Low Disease Activity and Disease Stability: Setting New Goals for COPD Care

    1234
    ...
    20